Brief: Takara Bio say first patient enrolled into phase I clinical trial of Oncolytic Virus HF10 in Japan
27/09/2017 07:49
Sept 27 (Reuters) - Takara Bio Inc 4974.T
* Says the first patient with pancreatic cancer has been
enrolled into Oncolytic Virus HF10(TBI-1401) phase I clinical
trial in Japan on Sept. 26
Source text in Japanese:https://goo.gl/8dhGnz
Further company coverage: 4974.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111;
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))